Letter: CCNU in teatment of recurrent medulloblastoma.
D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002528:Cerebellar Neoplasms / Q000188:drug therapy*; D002648:Child; D003510:Cyclohexanes / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008527:Medulloblastoma / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D011882:Radiotherapy, High-Energy; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003510:Cyclohexanes; D009607:Nitrosourea Compounds; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide